Levofloxacin is a Oral Tablet, Film Coated in the Human Prescription Drug category. It is labeled and distributed by Apotheca Inc.. The primary component is Levofloxacin.
| Product ID | 12634-674_47533163-35dc-00ae-e054-00144ff8d46c |
| NDC | 12634-674 |
| Product Type | Human Prescription Drug |
| Proprietary Name | Levofloxacin |
| Generic Name | Levofloxacin |
| Dosage Form | Tablet, Film Coated |
| Route of Administration | ORAL |
| Marketing Start Date | 2012-03-22 |
| Marketing Category | ANDA / ANDA |
| Application Number | ANDA200839 |
| Labeler Name | Apotheca Inc. |
| Substance Name | LEVOFLOXACIN |
| Active Ingredient Strength | 750 mg/1 |
| NDC Exclude Flag | N |
| Listing Certified Through | 2019-12-31 |
| Marketing Start Date | 2012-03-22 |
| NDC Exclude Flag | N |
| Sample Package? | N |
| Marketing Category | ANDA |
| Application Number | ANDA200839 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Marketing Start Date | 2012-03-22 |
| Inactivation Date | 2020-01-31 |
| Marketing Category | ANDA |
| Application Number | ANDA200839 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Marketing Start Date | 2012-03-22 |
| Inactivation Date | 2020-01-31 |
| Marketing Category | ANDA |
| Application Number | ANDA200839 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Marketing Start Date | 2012-03-22 |
| Inactivation Date | 2020-01-31 |
| Marketing Category | ANDA |
| Application Number | ANDA200839 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Marketing Start Date | 2012-03-22 |
| Inactivation Date | 2020-01-31 |
| Marketing Category | ANDA |
| Application Number | ANDA200839 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Marketing Start Date | 2012-03-22 |
| Inactivation Date | 2020-01-31 |
| Marketing Category | ANDA |
| Application Number | ANDA200839 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Marketing Start Date | 2012-03-22 |
| Inactivation Date | 2020-01-31 |
| Marketing Category | ANDA |
| Application Number | ANDA200839 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Marketing Start Date | 2012-03-22 |
| Inactivation Date | 2020-01-31 |
| Marketing Category | ANDA |
| Application Number | ANDA200839 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Marketing Start Date | 2012-03-22 |
| Inactivation Date | 2020-01-31 |
| Marketing Category | ANDA |
| Application Number | ANDA200839 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Marketing Start Date | 2012-03-22 |
| Inactivation Date | 2020-01-31 |
| Marketing Category | ANDA |
| Application Number | ANDA200839 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Marketing Start Date | 2012-03-22 |
| Inactivation Date | 2020-01-31 |
| Marketing Category | ANDA |
| Application Number | ANDA200839 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Marketing Start Date | 2012-03-22 |
| Inactivation Date | 2020-01-31 |
| Marketing Category | ANDA |
| Application Number | ANDA200839 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Marketing Start Date | 2012-03-22 |
| Inactivation Date | 2020-01-31 |
| Marketing Category | ANDA |
| Application Number | ANDA200839 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Marketing Start Date | 2012-03-22 |
| Inactivation Date | 2020-01-31 |
| Marketing Category | ANDA |
| Application Number | ANDA200839 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Marketing Start Date | 2012-03-22 |
| Inactivation Date | 2020-01-31 |
| Marketing Category | ANDA |
| Application Number | ANDA200839 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Marketing Start Date | 2012-03-22 |
| Inactivation Date | 2020-01-31 |
| Marketing Category | ANDA |
| Application Number | ANDA200839 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Marketing Start Date | 2012-03-22 |
| Inactivation Date | 2020-01-31 |
| Marketing Category | ANDA |
| Application Number | ANDA200839 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Marketing Start Date | 2012-03-22 |
| Inactivation Date | 2020-01-31 |
| Marketing Category | ANDA |
| Application Number | ANDA200839 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Marketing Start Date | 2012-03-22 |
| Inactivation Date | 2020-01-31 |
| Marketing Category | ANDA |
| Application Number | ANDA200839 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Marketing Start Date | 2012-03-22 |
| Inactivation Date | 2020-01-31 |
| Marketing Category | ANDA |
| Application Number | ANDA200839 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Marketing Start Date | 2012-03-22 |
| Inactivation Date | 2020-01-31 |
| Marketing Category | ANDA |
| Application Number | ANDA200839 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Marketing Start Date | 2012-03-22 |
| Inactivation Date | 2020-01-31 |
| Marketing Category | ANDA |
| Application Number | ANDA200839 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Marketing Start Date | 2012-03-22 |
| Inactivation Date | 2020-01-31 |
| Marketing Category | ANDA |
| Application Number | ANDA200839 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Marketing Start Date | 2012-03-22 |
| Inactivation Date | 2020-01-31 |
| Marketing Category | ANDA |
| Application Number | ANDA200839 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Marketing Start Date | 2012-03-22 |
| Inactivation Date | 2020-01-31 |
| Marketing Category | ANDA |
| Application Number | ANDA200839 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Marketing Start Date | 2012-03-22 |
| Inactivation Date | 2020-01-31 |
| Marketing Category | ANDA |
| Application Number | ANDA200839 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Marketing Start Date | 2012-03-22 |
| Inactivation Date | 2020-01-31 |
| Marketing Category | ANDA |
| Application Number | ANDA200839 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Marketing Start Date | 2012-03-22 |
| Inactivation Date | 2020-01-31 |
| Marketing Category | ANDA |
| Application Number | ANDA200839 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Marketing Start Date | 2012-03-22 |
| Inactivation Date | 2020-01-31 |
| Marketing Category | ANDA |
| Application Number | ANDA200839 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Marketing Start Date | 2012-03-22 |
| Inactivation Date | 2020-01-31 |
| Marketing Category | ANDA |
| Application Number | ANDA200839 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Marketing Start Date | 2012-03-22 |
| Inactivation Date | 2020-01-31 |
| Marketing Category | ANDA |
| Application Number | ANDA200839 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Marketing Start Date | 2012-03-22 |
| Inactivation Date | 2020-01-31 |
| Marketing Category | ANDA |
| Application Number | ANDA200839 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Marketing Start Date | 2012-03-22 |
| Inactivation Date | 2020-01-31 |
| Marketing Category | ANDA |
| Application Number | ANDA200839 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Marketing Start Date | 2012-03-22 |
| Inactivation Date | 2020-01-31 |
| Marketing Category | ANDA |
| Application Number | ANDA200839 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Marketing Start Date | 2012-03-22 |
| Inactivation Date | 2020-01-31 |
| Marketing Category | ANDA |
| Application Number | ANDA200839 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Marketing Start Date | 2012-03-22 |
| Inactivation Date | 2020-01-31 |
| Marketing Category | ANDA |
| Application Number | ANDA200839 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Marketing Start Date | 2012-03-22 |
| Inactivation Date | 2020-01-31 |
| Marketing Category | ANDA |
| Application Number | ANDA200839 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Marketing Start Date | 2012-03-22 |
| Inactivation Date | 2020-01-31 |
| Marketing Category | ANDA |
| Application Number | ANDA200839 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Marketing Start Date | 2012-03-22 |
| Inactivation Date | 2020-01-31 |
| Ingredient | Strength |
|---|---|
| LEVOFLOXACIN | 750 mg/1 |
| SPL SET ID: | 47079bd9-8d75-0c03-e054-00144ff8d46c |
| Manufacturer | |
| UNII | |
| RxNorm Concept Unique ID - RxCUI |
| NDC | Brand Name | Generic Name |
|---|---|---|
| 0121-0872 | Levofloxacin | Levofloxacin |
| 0143-9315 | Levofloxacin | Levofloxacin |
| 0143-9316 | Levofloxacin | Levofloxacin |
| 0143-9317 | Levofloxacin | Levofloxacin |
| 0143-9720 | Levofloxacin | Levofloxacin |
| 0143-9721 | Levofloxacin | Levofloxacin |
| 0143-9722 | Levofloxacin | Levofloxacin |
| 0143-9775 | Levofloxacin | Levofloxacin |
| 0143-9776 | Levofloxacin | Levofloxacin |
| 0143-9777 | Levofloxacin | Levofloxacin |
| 0409-0528 | LEVOFLOXACIN | LEVOFLOXACIN |
| 0527-1948 | Levofloxacin | Levofloxacin |
| 0781-5790 | Levofloxacin | Levofloxacin |
| 0781-5791 | Levofloxacin | Levofloxacin |
| 0781-5792 | Levofloxacin | Levofloxacin |
| 0904-6351 | Levofloxacin | Levofloxacin |
| 0904-6352 | Levofloxacin | Levofloxacin |
| 0904-6353 | Levofloxacin | Levofloxacin |
| 10544-143 | Levofloxacin | Levofloxacin |
| 10544-245 | Levofloxacin | Levofloxacin |
| 10544-451 | levofloxacin | levofloxacin |
| 68071-1860 | Levofloxacin | Levofloxacin |
| 68071-3089 | Levofloxacin | Levofloxacin |
| 68071-3051 | Levofloxacin | Levofloxacin |
| 68071-1932 | Levofloxacin | Levofloxacin |
| 68071-3091 | Levofloxacin | Levofloxacin |
| 68071-3093 | Levofloxacin | Levofloxacin |
| 68071-3166 | Levofloxacin | Levofloxacin |
| 68071-3218 | Levofloxacin | Levofloxacin |
| 68071-4101 | Levofloxacin | Levofloxacin |
| 68071-3271 | Levofloxacin | Levofloxacin |
| 68071-3236 | Levofloxacin | Levofloxacin |
| 68071-4422 | Levofloxacin | Levofloxacin |
| 68071-4340 | Levofloxacin | Levofloxacin |
| 68071-4547 | Levofloxacin | Levofloxacin |
| 68071-4623 | Levofloxacin | Levofloxacin |
| 68071-4726 | Levofloxacin | Levofloxacin |
| 68071-4512 | Levofloxacin | Levofloxacin |
| 68071-4738 | Levofloxacin | Levofloxacin |
| 68084-481 | Levofloxacin | Levofloxacin |
| 68084-483 | Levofloxacin | Levofloxacin |
| 68084-482 | Levofloxacin | Levofloxacin |
| 68180-240 | Levofloxacin | Levofloxacin |
| 68180-242 | Levofloxacin | Levofloxacin |
| 68180-241 | Levofloxacin | Levofloxacin |
| 68382-017 | levofloxacin | levofloxacin |
| 68382-015 | levofloxacin | levofloxacin |
| 68382-016 | levofloxacin | levofloxacin |
| 68382-989 | levofloxacin | levofloxacin |
| 68788-6938 | Levofloxacin | Levofloxacin |